Ajinomoto Bio-Pharma
Business Services · Japan · 51-200 Employees
View Company Info for Free
Overview
Headquarters
JapanWebsite
www.ajioligos.comRevenue
$28.6 MillionIndustry
About Ajinomoto Bio-Pharma
Is Ajinomoto Bio-Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Ajinomoto Bio-Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Ajinomoto Bio-Pharma launches new products
Funding: Get notified immidiatlly once Ajinomoto Bio-Pharma has new funding data
Earning: See what the market has to say on Ajinomoto Bio-Pharma recently announced quarterly report
Website visits: Recent activity has been detected on your website
Ajinomoto Bio-Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Ajinomoto Bio-Pharma
Click to see if Ajinomoto Bio-Pharma had a recent Job posting/layoffs
Check out if Ajinomoto Bio-Pharma is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Ajinomoto Bio-Pharma as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Ajinomoto Bio-Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ajinomoto Bio-Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ajinomoto Bio-Pharma.
Ajinomoto Bio-Pharma Tech Stack
A closer look at the technologies used by Ajinomoto Bio-Pharma
Top Business Services Companies
Frequently Asked Questions Regarding Ajinomoto Bio-Pharma
Aji Bio-Pharma specializes in the synthesis of DNA and RNA oligonucleotides, offering a range of services including CDMO, RNA sequence design, and contract analysis. Their product line includes research-grade oligonucleotides, RNA mimics, inhibitors, and peptides, catering to the needs of research and development in the biopharmaceutical sector. Th... Read More